Science Speaks

With a look at obstacles to accessing the newest tuberculosis treatments in the United States, and the ramifications of global TB data, the global Science Speaks blog highlighted needs for accelerated responses against an ancient disease with:

A report on compassionate use of a drug yet to receive approval from the U.S. Food and Drug Administration: Delamanid delay comes home;